RecruitingNCT06953245
Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy
Sponsor
Mayo Clinic
Enrollment
20 participants
Start Date
Apr 30, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This study evaluates patient-reported experiences of radiation dermatitis in patients with breast cancer undergoing radiotherapy.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study collects patient experiences with radiation-related skin reactions (called radiation dermatitis) in people with breast cancer undergoing radiation therapy. Researchers want to better understand how patients feel about their skin side effects and how these affect quality of life.
**You may be eligible if...**
- You are 18 or older
- You have been diagnosed with breast cancer
- You are currently receiving or have recently finished radiation therapy
- You are willing to share your experience verbally or in writing
**You may NOT be eligible if...**
- You are under 18 years old
- You are unable to provide verbal consent
- You do not speak English (unless translated materials are available)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNon-Interventional Study
Non-interventional study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06953245
Related Trials
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT0699589837 locations
Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen
NCT050568571 location
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
NCT070671381 location
Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients
NCT0561210023 locations
Prospective Study of Immune Alterations in Operable Breast and Ovarian Carcinoma
NCT045626231 location